Christopher W. Fulton

Array ( [id] => 7720818 [patent_doc_number] => 20120010153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'NOVEL TUMOR-TARGETING COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/144416 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8846 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010153.pdf [firstpage_image] =>[orig_patent_app_number] => 13144416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807984 [patent_doc_number] => 08445636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Antimicrobial and anticancer lipopeptides' [patent_app_type] => utility [patent_app_number] => 12/685202 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 13294 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12685202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580863 [patent_doc_number] => 20110294746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'PHARMACEUTICAL MICROEMULSION FOR PREVENTING SUPRAMOLECULAR AGGREGATION OF AMPHIPHILIC MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/143241 [patent_app_country] => US [patent_app_date] => 2010-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9156 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294746.pdf [firstpage_image] =>[orig_patent_app_number] => 13143241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320443 [patent_doc_number] => 20100113362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHODS FOR INHIBITING IMMUNE COMPLEX FORMATION IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 12/651664 [patent_app_country] => US [patent_app_date] => 2010-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21025 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113362.pdf [firstpage_image] =>[orig_patent_app_number] => 12651664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587284 [patent_doc_number] => 20110281794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => ' COMPOSITION COMPRISING NOR-ADRENALINE AND AMPHETAMINE FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR' [patent_app_type] => utility [patent_app_number] => 13/141469 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8854 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281794.pdf [firstpage_image] =>[orig_patent_app_number] => 13141469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580853 [patent_doc_number] => 20110294736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE' [patent_app_type] => utility [patent_app_number] => 13/141198 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 12539 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294736.pdf [firstpage_image] =>[orig_patent_app_number] => 13141198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6423539 [patent_doc_number] => 20100167996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => '3-Ether and 3-Thioether Substituted Cyclosporin Derivatives For the Treatment and Prevention of Hepatitis C Infection' [patent_app_type] => utility [patent_app_number] => 12/643860 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19181 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167996.pdf [firstpage_image] =>[orig_patent_app_number] => 12643860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968836 [patent_doc_number] => 08507647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Antibacterial agents for the treatment of gram positive infections' [patent_app_type] => utility [patent_app_number] => 12/641465 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21204 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12641465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292379 [patent_doc_number] => 20100159482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/642322 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26388 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20100159482.pdf [firstpage_image] =>[orig_patent_app_number] => 12642322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6443695 [patent_doc_number] => 20100144603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHODS AND USES THEREOF OF PROSAPOSIN' [patent_app_type] => utility [patent_app_number] => 12/640788 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 47061 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144603.pdf [firstpage_image] =>[orig_patent_app_number] => 12640788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083631 [patent_doc_number] => 20110144026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Method of Treating Low Blood Pressure' [patent_app_type] => utility [patent_app_number] => 12/639987 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1806 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144026.pdf [firstpage_image] =>[orig_patent_app_number] => 12639987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636990 [patent_doc_number] => 20100173827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'ROLE OF PROLINE RICH PEPTIDES IN CELLULAR COMMUNICATION MECHANISMS AND TREATMENT OF DISEASES' [patent_app_type] => utility [patent_app_number] => 12/639885 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20833 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173827.pdf [firstpage_image] =>[orig_patent_app_number] => 12639885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153805 [patent_doc_number] => 08586711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Polymer-factor IX moiety conjugates' [patent_app_type] => utility [patent_app_number] => 12/638811 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 22267 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12638811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594335 [patent_doc_number] => 20100130684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'POLYMER FACTOR IX MOIETY CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/638744 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22137 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130684.pdf [firstpage_image] =>[orig_patent_app_number] => 12638744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249688 [patent_doc_number] => 20100137511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'POLYMER FACTOR IX MOIETY CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/638874 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22258 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137511.pdf [firstpage_image] =>[orig_patent_app_number] => 12638874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6589613 [patent_doc_number] => 20100130428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'POLYMER FACTOR IX MOIETY CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/638904 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22265 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130428.pdf [firstpage_image] =>[orig_patent_app_number] => 12638904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807978 [patent_doc_number] => 20120058932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'ACTIVE INGREDIENT-PEPTIDE CONSTRUCT FOR EXTRACELLULAR CONCENTRATION' [patent_app_type] => utility [patent_app_number] => 13/132695 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12678 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058932.pdf [firstpage_image] =>[orig_patent_app_number] => 13132695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495437 [patent_doc_number] => 20120294845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'METHOD OF MAKING A POLYMER PREFERABLY AN (ALKYL) ACRYLOYL POLYCARBONATE, THE POLYMER AND (ALKYL) ACRYLOYL POLYCARBONATE OBTAINED, AND A BIODEVICE COMPRISING SAME' [patent_app_type] => utility [patent_app_number] => 13/386238 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7875 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616648 [patent_doc_number] => 20100099727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Amino acid and peptide conjugates of arylalkylic acids for cosmetic use' [patent_app_type] => utility [patent_app_number] => 12/591663 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10167 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099727.pdf [firstpage_image] =>[orig_patent_app_number] => 12591663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594916 [patent_doc_number] => 20100130723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'POLYPEPTIDE SYNTHESIS FOR DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/623584 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11644 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130723.pdf [firstpage_image] =>[orig_patent_app_number] => 12623584 [rel_patent_id] =>[rel_patent_doc_number] =>)